Radiation Oncology/Therapy: Page 50

Fusion Pharmaceuticals to build radiopharma plant in Canada

By AuntMinnie.com staff writers

McMaster University spin-off company Fusion Pharmaceuticals announced it has entered a 15-year lease agreement with the school for a new manufacturing facility for therapeutic pharmaceuticals near its campus in Hamilton, Ontario.

June 2, 2021

GenesisCare among early providers to offer Pylarify

By AuntMinnie.com staff writers

Lantheus Medical Imaging has announced that oncology provider GenesisCare will be the first to administer commercially available doses of its Pylarify PET radiopharmaceutical, which was approved last month.

June 2, 2021

RaySearch releases update of RayStation software

By AuntMinnie.com staff writers

Radiation therapy software developer RaySearch Laboratories has released 11A, a new version of its RayStation treatment planning software.

June 1, 2021

Elekta reaches Elekta Unity milestone

By AuntMinnie.com staff writers

Radiation oncology vendor Elekta has installed its 100th Unity MR-Linac system at St. George's Hospital in Christchurch, New Zealand.

May 31, 2021

Varian nets FDA breakthrough nod for radioablation unit

By AuntMinnie.com staff writers

Radiation oncology vendor Varian Medical Systems has garnered a breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its cardiac radioablation system.

May 27, 2021

Blue Earth touts Axumin results in Lancet

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting results of a study published in Lancet showing that postprostatectomy radiation therapy guided by the company's PET radiotracer Axumin (fluciclovine F-18) helped increase biochemical event-free survival rates in men with recurrent prostate cancer.

May 26, 2021

NorthStar partners with Clarity, Monopar

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and radiopharmaceutical firm Clarity Pharmaceuticals are joining forces on the supply of the therapeutic radioisotope copper-67. NorthStar is also partnering with biopharmaceutical firm Monopar Therapeutics on a patent.

May 24, 2021

RSNA R&E grant study identifies new biomarker for NSCLC

By AuntMinnie.com staff writers

Research conducted under the auspices of an RSNA Research and Education Foundation grant has identified a new, noninvasive biomarker that could help monitor the treatment response of non-small cell lung cancer (NSCLC).

May 23, 2021

Zap announces Swiss installation of brain tumor system

By AuntMinnie.com staff writers

Zap Surgical Systems announced that its new Zap-X gyroscopic radiosurgery platform for the treatment of brain tumors will be installed at a center in Switzerland.

May 12, 2021

BWXT to manufacture Boston Scientific's TheraSphere glass microspheres

By AuntMinnie.com staff writers

Medical isotope and radiopharmaceutical supplier BWXT Medical has signed an agreement with Boston Scientific to manufacture that firm's TheraSphere yttrium-90 glass microspheres.

May 9, 2021

GE Healthcare acquires Zionexa

By AuntMinnie.com staff writers

GE Healthcare announced it has acquired biomarker developer Zionexa.

May 5, 2021

Varian lands big linac sale in Australia

By AuntMinnie.com staff writers

Varian has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and treatment software to help tackle the growing global cancer burden in the country.

April 29, 2021

Previous Page

Page 50 of 464

Next Page